Bausch Pulls Xifaxan From Medicaid/340B As Medicare Negotiated Price Looms

 
• By Cathy Kelly
  
Xifaxan sales in Medicaid and 340B may have become a liability. (Shutterstock)

More from Medicaid

More from Government Payers